Normalisation of circulating neutrophil counts after 12 months of elexacaftor-tezacaftor-ivacaftor in patients with advanced cystic fibrosis
Théo Dhôte, Clémence Martin, Lucile Regard, Lucie Pesenti, Reem Kanaan, Nicolas Carlier, Isabelle Honoré, Jennifer Da Silva, Véronique Witko‐Sarsat, Pierre‐Régis Burgel
Abstract
<b>In people with cystic fibrosis and advanced lung disease, circulating neutrophils were often elevated under clinically stable conditions. Treatment with elexacaftor-tezacaftor-ivacaftor for 12 months is associated with normalisation of neutrophil counts.</b> http://bit.ly/3gtgDFx
Topics & Concepts
IvacaftorCystic fibrosisMedicineInternal medicineDiseaseGastroenterologyPathologyCystic fibrosis transmembrane conductance regulatorCystic Fibrosis Research AdvancesTracheal and airway disordersNeonatal Respiratory Health Research